Search MEDiscuss
81 results, showing 1–10
-
CURB-65 and CRB-65: The Evidence Behind the Toolmediscuss.org › curb-65-and-crb-65-evidence-behind-the-tool
Why CRB-65 was built for the clinic without a laboratory, why a BUN must be turned into blood urea before it is scored, what an Indian validation study found, and why a low score is a floor and not a ceiling: the evidence behind the MEDiscuss CDSS CURB-65 / CRB-65 Pneumonia Severity tool.
-
The Glasgow Coma Scale and GCS-P: The Evidence Behind the Toolmediscuss.org › glasgow-coma-scale-and-gcs-p-evidence-behind-the-tool
Where the Glasgow Coma Scale came from, how to score the three domains, why the pupils were added as GCS-P, what to record when a domain cannot be tested, and why the trend matters more than one reading: the evidence behind the MEDiscuss CDSS Glasgow Coma Scale & GCS-P tool.
-
Thyrotoxicosis: The Evidence Behind the Pathwaymediscuss.org › thyrotoxicosis-evidence-behind-the-pathway
Why the cause of thyrotoxicosis decides the first drug, how the examination, TRAb and the uptake scan tell Graves' disease, thyroiditis and the toxic nodule apart, which beta-blocker to give, and when PTU replaces methimazole: the evidence behind the MEDiscuss CDSS Thyrotoxicosis Pathway.
-
ATT Hepatitis: The Evidence Behind the Pathwaymediscuss.org › att-hepatitis-evidence-behind-the-pathway
When a rise in the liver enzymes on anti-tubercular therapy is adaptation and when it is injury, when to stop, which drug is the likely culprit and how it harms the liver, how to bridge without the liver drugs, and how to bring them back one at a time: the evidence behind the MEDiscuss CDSS ATT Hepatitis (DILI) Pathway.
-
Acute Hypercalcaemia: The Evidence Behind the Protocolmediscuss.org › acute-hypercalcaemia-evidence-behind-the-protocol
Why a high calcium leaves the patient so dry, why saline comes first and furosemide does not, why the bisphosphonate needs a bridge, and why tuberculosis can raise the calcium: the evidence behind the MEDiscuss CDSS Acute Hypercalcaemia protocol.
-
Acute Hypernatraemia: The Evidence Behind the Protocolmediscuss.org › acute-hypernatraemia-evidence-behind-the-protocol
How to work out a free water deficit and why it is only a floor, how fast a high sodium may be brought down and why, what the evidence behind the speed limit actually shows, which fluid to use, and when the urine points to diabetes insipidus: the evidence behind the MEDiscuss CDSS Acute Hypernatraemia protocol.
-
Acute Hypomagnesaemia: The Evidence Behind the Protocolmediscuss.org › acute-hypomagnesaemia-evidence-behind-the-protocol
Why a low potassium will not rise until the magnesium is corrected, how much intravenous magnesium to give and how fast, what to watch for, why a proton pump inhibitor keeps the level down, which tablet to choose, and why torsades de pointes gets magnesium whatever the level: the evidence behind the MEDiscuss CDSS Acute Hypomagnesaemia protocol.
-
Seizures and Anti-Seizure Medicines: The Evidence Behind the Pathwaymediscuss.org › seizures-anti-seizure-medicines-evidence-behind-the-pathway
What to do in the first minutes of status epilepticus, how to choose and load the second drug, why phenytoin is diluted in saline and given slowly, why valproate is avoided in a young woman, how each anti-seizure medicine works and why that is not how we choose one: the evidence behind the MEDiscuss CDSS Seizure and ASM Dosing Pathway.
-
Opportunistic Infection Prophylaxis in HIV: The Evidence Behind the Pathwaymediscuss.org › oi-prophylaxis-hiv-evidence-behind-the-pathway
When cotrimoxazole starts and when it stops, which TB preventive treatment to give and to whom, why a low CD4 count calls for a cryptococcal antigen test, and how each prophylaxis is kept safe: the evidence behind the MEDiscuss CDSS OI Prophylaxis Pathway.
-
AF Anticoagulation: The Evidence Behind the Pathwaymediscuss.org › af-anticoagulation-evidence-behind-the-pathway
Why a NOAC is contraindicated in rheumatic valvular AF, how to read the sex point of CHA2DS2-VASc, why renal function no longer adds stroke points, why a high HAS-BLED score is not a reason to withhold anticoagulation, and how to choose and dose the drug: the evidence behind the MEDiscuss CDSS AF Anticoagulation Pathway.